Thirona

Thirona is a leader in AI-driven lung image analysis, leveraging over two decades of research to transform subjective CT scan interpretation into objective, quantitative data. Its core LungQ platform is extensively validated and used globally by hospitals and pharmaceutical companies to characterize complex respiratory diseases like COPD, severe asthma, and cystic fibrosis. The company operates a B2B platform and services model, generating revenue by accelerating clinical trials and enabling precision pulmonary interventions.

LungQ platform: AI-powered software for automated segmentation and quantification of lung structures (bronchi, vessels, parenchyma) from thoracic CT scans, delivering objective metrics for disease assessment.

Thirona competes in the AI medical imaging market, facing potential competition from large generalist radiology AI vendors (e.g., Aidoc, Zebra Medical) and other specialized lung image analysis startups. Its deep validation in large cohorts like COPDGene and focus solely on thoracic imaging are key differentiators against broader platforms.